This week's Fierce Biotech is brought to you by Integral.

Webinar: Redefining Antibody Specificity Profiling for IND

Thursday June 6, 2024 | 11am ET/ 8am PT

Join our webinar to learn about the new, innovative cell-based protein array approach to specificity profiling. We’ll take a deep dive into the Membrane Proteome Array (MPA), a 6,000-protein array platform that tests binding of biotherapeutics across the full human membrane proteome expressed in unfixed cells.

Attendees will learn how:

• Integral Molecular’s MPA is used to rapidly and accurately identify potential off-target binding liabilities
• MPA data support both lead selection and IND submissions with advantages over tissue cross-reactivity studies
• Cell protein arrays, like the MPA, are rapidly progressing towards FDA endorsement through inclusion in CAR-T development guidelines and qualification as an antibody Drug Development Tool